Expression of RANKL/OPG during bone remodeling in vivo.
暂无分享,去创建一个
C. Liang | T. Mine | H. Tanaka | T. Taguchi | T. Mine | H. Ogasa | C. T. Liang | Hiroshi Tanaka | Toshihiko Taguchi
[1] T. Silva,et al. Imbalance of RANK, RANKL and OPG expression during tibial fracture repair in diabetic rats , 2008, Journal of Molecular Histology.
[2] Xing Wang,et al. Temporal and spatial expression of osteoprotegerin and receptor activator of nuclear factor -kappaB ligand during mandibular distraction in rats. , 2007, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.
[3] E. Bonucci,et al. Detection of osteoprotegerin (OPG) and its ligand (RANKL) mRNA and protein in femur and tibia of the rat , 2005, Journal of Molecular Histology.
[4] A. Evdokiou,et al. RANKL Expression Is Related to the Differentiation State of Human Osteoblasts , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[5] C. Liang,et al. Effect of IGF-I and PDGF administered in vivo on the expression of osteoblast-related genes in old rats. , 2002, The Journal of endocrinology.
[6] J. Eisman,et al. Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts. , 2001, The Journal of endocrinology.
[7] T A Einhorn,et al. Expression of Osteoprotegerin, Receptor Activator of NF‐κB Ligand (Osteoprotegerin Ligand) and Related Proinflammatory Cytokines During Fracture Healing , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[8] B. Riggs,et al. The Expression of Osteoprotegerin and RANK Ligand and the Support of Osteoclast Formation by Stromal-Osteoblast Lineage Cells Is Developmentally Regulated* *This work was supported by Grant AG-04875 from the National Institute on Aging. , 2000, Endocrinology.
[9] T. Martin,et al. Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues. , 1999, Bone.
[10] I. Lukić,et al. Genetic variability of new bone induction in mice. , 1999, Bone.
[11] S. Morony,et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[12] D. Lacey,et al. Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation , 1998, Cell.
[13] K Yano,et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[14] S. Mochizuki,et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. , 1998, Endocrinology.
[15] G Shimamoto,et al. Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density , 1997, Cell.
[16] R. Quarto,et al. In vivo and in vitro effects of insulin-like growth factor-I (IGF-I) on femoral mRNA expression in old rats. , 1994, Bone.
[17] G. Rodan,et al. Impaired bone activity in aged rats: alterations at the cellular and molecular levels. , 1992, Bone.
[18] S. Miller,et al. Differences in cortical bone in overloaded and underloaded femurs from ovariectomized rats: comparison of bone morphometry with torsional testing. , 1992, Bone.
[19] G. Rodan,et al. Different pattern of alkaline phosphatase, osteopontin, and osteocalcin expression in developing rat bone visualized by in situ hybridization , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[20] M. Sato,et al. Effects of bisphosphonates on isolated Rat osteoclasts as examined by reflected light microscopy , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[21] M. Bolander,et al. Isolation and analysis of ribonucleic acids from skeletal tissues. , 1989, Analytical biochemistry.
[22] G. Rodan,et al. Tissue specificity and developmental expression of rat osteopontin. , 1987, Biochemical and biophysical research communications.
[23] H. Harris,et al. cDNA cloning of alkaline phosphatase from rat osteosarcoma (ROS 17/2.8) cells , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[24] R. Turner,et al. Demonstration that ethanol inhibits bone matrix synthesis and mineralization in the rat , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[25] D. Rowe,et al. Construction of DNA sequences complementary to rat alpha 1 and alpha 2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D. , 1984, Biochemistry.
[26] Patt Hm,et al. Bone marrow regeneration after local injury: a review. , 1975 .